The Government of India, through the National Pharmaceutical Pricing Authority (NPPA), has capped the trade margin at 30% on 137 anti-cancer medicines. The aim is to make cancer treatment more affordable for patients.
Patients and partners with questions about the revised prices are welcome to speak to their doctor, pharmacist or hospital.
Source: NPPA Order S.O. 5690(E), The Gazette of India, 17 October 2026.
Generics (Alpha) Division is Hetero Healthcare's initiative to bring affordable and effective healthcare solutions closer to every patient. It delivers a comprehensive range of medicines across multiple therapeutic categories, including infectious diseases, cardiovascular health, pain management, gastroenterology, and nutritional care. Generics Alpha Division helps healthcare professionals deliver reliable treatment options, while extending quality medical aid to underserved regions and across the nation.
View by-
